{
    "medicine_id": "74764b8b110528192149b74b98a576cbde8b9fe8",
    "platform_id": "DB05439",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v IDD 1",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in prostate cancer",
            "contraindications": {
                "disease": "MoABs have been reported to have low toxicity as they successfully target the tumor cells",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "IDD 1 specifically targets cancer cells by simulating a natural immune response IDD 1 is produced by coupling dendritophages with tumor antigens obtained from the individual patient The resulting vaccine is then reinjected into the subject",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}